Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) shares traded -2.14% lower at $17.35 on Wall Street last session.
TEVA stock price is now -11.53% away from the 50-day moving average and -1.59% away from the 200-day moving average. The market capitalization of the company currently stands at $19.69B.
With the price target maintained at $20, Argus recently Upgraded its rating from Hold to Buy for Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA). On March 08, 2024, JP Morgan Upgraded its previous ‘Underweight’ rating to ‘Neutral’ on the stock keeping its target price maintained at $14, while ‘Piper Sandler’ rates the stock as ‘Overweight’
In other news, MIGNONE ROBERTO, Director sold 286,000 shares of the company’s stock on Dec 20 ’24. The stock was sold for $6,294,031 at an average price of $22.01. Upon completion of the transaction, the Director now directly owns 695,000 shares in the company, valued at $12.06 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 20 ’24, Shareholder Bridger Management, LLC (1) bought 286,000 shares of the business’s stock. A total of $6,094,660 was incurred on buying the stock at an average price of $21.31. A total of 0.00% of the company’s stock is owned by insiders.
During the past 12 months, Teva- Pharmaceutical Industries Ltd. ADR has had a low of $11.83 and a high of $22.80. As of last week, the company has a debt-to-equity ratio of 3.18, a current ratio of 0.89, and a quick ratio of 0.61. The fifty day moving average price for TEVA is $19.5938 and a two-hundred day moving average price translates $17.60815 for the stock.
The latest earnings results from Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) was released for 2024-09-30. The net profit margin was -5.72% and return on equity was -14.76% for TEVA. The company reported revenue of $4.33 billion for the quarter, compared to $3.85 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.52 percent. For the current quarter, analysts expect TEVA to generate $4B in revenue.
